White House Weighs Stakes in Defense Stocks, Eli Lilly Clears Hurdle for Weight-Loss Pill
The Rundown
00:00
State-Sponsored Capitalism and Breakthroughs in Weight Loss Medication
This chapter examines the potential risks of state-sponsored capitalism in the U.S., particularly focusing on major companies like Intel and Lockheed Martin. It also highlights Eli Lilly's advancements with a new weight loss pill, Orv for Glyprin, which could revolutionize the market by offering a more accessible alternative to current treatments.
Transcript
Play full episode
